As we move through 2026, the global pharmaceutical sector is proving that environmental sustainability and financial profitability are no longer mutually exclusive. "Green Chemistry" has transitioned from a niche corporate social responsibility (CSR) initiative to a fundamental pillar of modern drug synthesis. By designing chemical processes that reduce or eliminate the use of hazardous...